Detailed price information for Gyre Therapeutics Inc (GYRE-Q) from The Globe and Mail including charting and trades.
Hosted on MSN
Key North Atlantic current is on the brink of collapse - plunging us into a 'Little Ice Age'
A key ocean current in the North Atlantic Ocean is weakening to the point of total collapse due to climate change, a new study warns. Scientists say the North Atlantic Subpolar Gyre – a massive system ...
Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.02 per share a year ago.
Gyre Therapeutics reported Q1 2025 revenue of $22.1 million and provided updates on clinical trials and product launches. Gyre Therapeutics reported Q1 2025 revenue of $22.1 million and a GAAP basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results